Drug Shortage Report for PMS-NYSTATIN SUSPENSION 100000 UNIT/ML
Report ID | 171759 |
Drug Identification Number | 00792667 |
Brand name | PMS-NYSTATIN SUSPENSION 100000 UNIT/ML |
Common or Proper name | NYSTATIN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | NYSTATIN |
Strength(s) | 100000UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 500 ML |
ATC code | A07AA |
ATC description | INTESTINALANTIINFECTIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-10-14 |
Estimated end date | 2023-02-24 |
Actual end date | 2023-02-22 |
Shortage status | Resolved |
Updated date | 2023-02-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2023-02-24 | French | Compare |
v20 | 2023-02-24 | English | Compare |
v19 | 2023-02-20 | French | Compare |
v18 | 2023-02-20 | English | Compare |
v17 | 2023-02-07 | French | Compare |
v16 | 2023-02-07 | English | Compare |
v15 | 2023-01-23 | French | Compare |
v14 | 2023-01-23 | English | Compare |
v13 | 2023-01-09 | French | Compare |
v12 | 2023-01-09 | English | Compare |
v11 | 2023-01-09 | French | Compare |
v10 | 2023-01-09 | English | Compare |
v9 | 2023-01-06 | French | Compare |
v8 | 2023-01-06 | English | Compare |
v7 | 2022-12-07 | French | Compare |
v6 | 2022-12-07 | English | Compare |
v5 | 2022-11-08 | French | Compare |
v4 | 2022-11-08 | English | Compare |
v3 | 2022-10-15 | English | Compare |
v2 | 2022-10-14 | French | Compare |